The APP gene test is a blood or saliva test that looks for harmful changes in the amyloid precursor protein gene. When you seek a dementia second opinion, a positive result strongly points to Alzheimer pathology, while a negative result does not rule out Alzheimer's.
It helps only a small group, mainly families with very early memory loss. Use the second opinion to review the diagnosis, records, and family pattern before testing. Bring full history and expect counseling about family effects and follow-up options.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How accurate is APP testing?
- Do you need it for a second opinion?
- How should you prepare?
- What happens after the result?
How accurate is APP testing?
According to MedlinePlus, variants in APP cause early-onset Alzheimer's beginning before age 65 but account for less than 10% of early-onset cases MedlinePlus APP gene page. That rarity matters. Most dementia, even early dementia, has other causes. In a person who already meets clinical criteria for probable dementia, the NIA-Alzheimer's Association criteria state that finding a causative APP, PSEN1, or PSEN2 mutation raises certainty that Alzheimer pathology caused the impairment NIA-Alzheimer's Association criteria document.
Absence of a variant does not rule out Alzheimer's. Clinical exams, scans, and labs still carry more weight for most patients. Think of the test as confirmatory, not screening. It rarely finds an answer without a strong early-onset family pattern. A second-opinion neurologist will weigh age at onset, exam findings, and imaging first.
Do you need it for a second opinion?
Often no. ARUP Consult notes that single-gene APP testing is generally not recommended unless a known familial variant exists ARUP Consult early-onset Alzheimer review. The second opinion usually focuses on records, scans, medicines, and other causes of decline. Consider testing when several blood relatives had Alzheimer's before age 65, especially before age 60.
AlzForum's summary of joint genetics guidelines describes APP, PSEN1, and PSEN2 changes as autosomal dominant. That means a child of a carrier has a 50% chance of inheriting the variant. A genetics-aware second opinion can map a three-generation pedigree and judge fit. If the pedigree fits, the clinician may order a broader dementia gene panel rather than APP alone. If it does not fit, further workup for other dementias is more useful.
How should you prepare?
Bring a complete packet to the visit. Include prior clinic notes, brain scans, blood work, a full medicine and supplement list, and family history with ages at first symptoms.
Expect formal pre-test and post-test counseling with Alzheimer genetics expertise, as outlined in joint ACMG and NSGC guidance. The session should cover test purpose, what positive and negative results mean, family effects, and support needs. Bring a trusted support person and be ready for baseline neurologic and mood checks.
- Prior dementia evaluations, neuropsychological test scores, and hospital records
- MRI or CT and PET images on disc, plus lab results
- All prescription drugs, over-the-counter drugs, sleep aids, and alcohol use
- Three generations of relatives with memory loss, age at onset, and cause of death
What happens after the result?
A positive APP result shifts care toward family planning and research options. Ask for referral for family counseling and discussion of predictive testing for adult relatives at risk. Each adult child can then decide with a counselor whether to test, when, and with what support.
For families with a concerning pedigree or positive result, Alzheimers.gov points to the Dominantly Inherited Alzheimer Network registry with no-cost counseling, imaging, and biomarker follow-up Alzheimers.gov DIAN trial page. Participation can include monitoring over time and possible trial eligibility. It does not replace routine dementia care. Ask the second-opinion clinic for a written pedigree and referral letter you can share with relatives and their clinicians.
